Part-Time
Posted on 9/23/2025
Digital addiction treatment with contingency management
No salary listed
Montana, USA
Remote
Requires active PMHNP license in Montana; multi-state licensure; telehealth; must have quiet private office; 100% remote
Affect Therapeutics provides digital addiction recovery services that combine contingency management with therapy and medication. The platform is private, fully online, and accessible via secure video conferencing, removing the need to visit clinics. It uses financial incentives to reward healthy behaviors, helping users build new habits, and offers holistic support such as job search, housing guidance, and bill management to improve overall life circumstances. The business likely operates on a subscription or fee-for-service model to fund ongoing treatment and support. Compared to traditional clinics, the service emphasizes digital convenience, privacy, and integrated life-support, aiming to help people recover from addiction and improve their broader daily life.
Company Size
51-200
Company Stage
Series B
Total Funding
$49M
Headquarters
New York City, New York
Founded
2020
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Remote Work Options
Professional Development Budget
Affect Therapeutics, a digital mental health and addiction treatment provider, has raised $26M in a Series B funding round led by Allumia Ventures. The company offers therapy, medical support, and a gamified app for conditions like depression, PTSD, anxiety, OCD, and substance use disorders. It operates in several U.S. states and accepts major insurance plans. Previously, Affect Therapeutics raised $23M, including a $16M Series A in 2023.
Affect Therapeutics, a provider of all-digital addiction treatment programs, raised $16 million in a Series A round led by Artis Ventures.
Affect Therapeutics, a McLean, VA-based company providing addiction treatment for the digital age, raised $16M in Series A funding.The round was led by ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures. Stuart Peterson of ARTIS Ventures has joined the Board, and Dr. Imran Hamid of LifeArc Ventures joined the Board as an observer. The company intends to use the funds to enable national expansion, program expansion, and engineering innovation in the Affect app.Founded in 2020, Affect Therapeutics offers clinically intensive treatment that follows a scientifically-proven program supporting the entire recovery journey via a smartphone app for drug and alcohol addiction. The approach, based on the best research in the field including its own NIH-sponsored studies, combines experts at unlocking behavior change and motivation, with members receiving rewards for success in treatment, including engagement and provision of negative drug and alcohol screens. The company’s approach couples this type of cognitive behavioral therapy with counseling, medical oversight, and case management, delivering a comprehensive program based on decades of research.Affect currently holds outpatient treatment licenses in 20 states and aims to serve a majority of the U.S. population by the end of 2023
Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by TechBio-focused ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures.
There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech, and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software. So when Affect’s $1 million seed round from AlleyCorp came to my attention, I wanted to learn a bit more.